Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference43 articles.
1. Yu T, Enioutina EY, Brunner HI, Vinks AA, Sherwin CM. Clinical pharmacokinetics and pharmacodynamics of biologic therapeutics for treatment of systemic lupus erythematosus. Clin Pharm. 2017;56(2):107–25.
2. Morand EF, Furie R, Tanaka Y, Bruce IN, Askanase AD, Richez C, et al. Trial of anifrolumab in active systemic lupus erythematosus. NEJM Mass Med Soc. 2020;382(3):211–21.
3. Hougardy D, Peterson G, Bleasel M, Randall C. Is enough attention being given to the adverse effects of corticosteroid therapy? J Clin Pharma Ther. 2000;25(3):227–34.
4. Fardet L, Flahault A, Kettaneh A, Tiev K-P, Généreau T, Tolédano C, et al. Corticosteroid-induced clinical adverse events: frequency, risk factors and patient’s opinion. Brit J Dermatol. 2007;157(1):142–8.
5. McDonough AK, Curtis JR, Saag KG. The epidemiology of glucocorticoid-associated adverse events. Curr Opin Rheumatol. 2008;20(2):131–7.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献